The β-cell glucose toxicity hypothesis: Attractive but difficult to prove

Gordon C Weir1, Peter C Butler2, Susan Bonner-Weir1

  • 1Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.

Insights

High blood glucose in diabetes alters beta cell function, but mechanisms remain unclear. New research questions the simple glucose toxicity hypothesis, suggesting complex feedback loops may be involved.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cell Biology

Background:

  • Diabetes mellitus is characterized by hyperglycemia, leading to significant changes in pancreatic beta cell phenotype and function.
  • These beta cell alterations are often reversible with normalization of glucose levels, supporting the concept of glucose toxicity.
  • However, the precise molecular mechanisms underlying glucose toxicity and its impact on beta cells are not well-defined.

Purpose of the Study:

  • To investigate the mechanisms by which elevated glucose levels affect pancreatic beta cell function in diabetes.
  • To critically evaluate the prevailing glucose toxicity hypothesis in light of early diabetes development.
  • To explore potential complex feedback mechanisms between insulin secretion and insulin action.

Main Methods:

  • The study reviews existing literature and postulates new experimental approaches to investigate beta cell dysfunction in diabetes.
  • Focuses on analyzing the early stages of diabetes, particularly the loss of first-phase insulin release (FPIR).
  • Examines the relationship between impaired insulin action in peripheral tissues and compensatory insulin secretion.

Main Results:

  • Observed a significant loss of glucose-induced first-phase insulin release (FPIR) in the early stages of diabetes, even with minimal blood glucose elevation.
  • Identified complexities in understanding how impaired insulin action on target tissues might lead to increased insulin secretion.
  • Highlighted difficulties in measuring expected blood glucose level increases, challenging simple feedback models.

Conclusions:

  • The simplicity of the glucose toxicity hypothesis and basic feedback mechanisms may not fully explain the observed complexities in diabetes pathophysiology.
  • Further research with novel experimental strategies is required to elucidate the intricate relationship between glucose, beta cell function, and insulin action.
  • Glucose may indeed drive these changes, but the underlying mechanisms necessitate a re-evaluation and development of new hypotheses.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
465
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K